Rationale for First-Line CPT-11 Combination Therapy
Different mechanism of action from 5-FU
Hypothesis: First-line combination of CPT-11 with 5-FU/LV will further improve tumor control and survival
- Active as first-line, single-agent therapy
- Extends survival when used as second-line therapy